CGC - Canopy Growth Corp


1.185
-0.035   -2.954%

Share volume: 18,662,097
Last Updated: 04-24-2026
Pharmaceutical Products/Medicinal Chemicals: 0.28%

PREVIOUS CLOSE
CHG
CHG%

$1.22
-0.03
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
58%
Profitability 50%
Dept financing 42%
Liquidity 57%
Performance 70%
Company vs Stock growth
vs
Performance
5 Days
-14.13%
1 Month
32.64%
3 Months
1.28%
6 Months
-10.23%
1 Year
-11.57%
2 Year
-21.00%
Key data
Stock price
$1.18
P/E Ratio 
0.00
DAY RANGE
$1.14 - $1.23
EPS 
-$1.07
52 WEEK RANGE
$0.84 - $2.38
52 WEEK CHANGE
-$11.57
MARKET CAP 
390.103 M
YIELD 
N/A
SHARES OUTSTANDING 
377.863 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-29-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$28,928,911
AVERAGE 30 VOLUME 
$15,298,814
Company detail
CEO: David E. Klein
Region: US
Website: canopygrowth.com
Employees: 3,150
IPO year: 2014
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Canopy Growth Corporation engages in the production, distribution, and sale of cannabis and hemp-based products. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes.

Recent news